← Estee Lauder Companies overview

Estee Lauder Companies vs LOréal: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Estee Lauder Companies Inc (EL)

Q3 2026
▲2▼2

Estée Lauder's Turnaround Gains Traction, But Risks Linger

  • Analyst Upgrades and Strong Sales Goldman Sachs reinstated a Buy rating and Barclays upgraded the stock, while Q4 sales rose 6% to $3.63 billion, signaling growing confidence in the turnaround.

    This point highlights the positive impact of analyst actions and sales growth on investor sentiment.

  • Fiscal 2026 Beat and Optimistic Guidance Fiscal 2026 beat targets with organic sales up 3% and operating margin expanding to 11.2%, and fiscal 2027 EPS guidance topped estimates, driven by luxury fragrance and China demand.

    This point shows the company's financial performance and future outlook, key drivers of the stock.

  • Restructuring Charges and Data Breach Restructuring charges rose to about $1.75 billion and a data breach created regulatory and reputational exposure, posing risks to the company's recovery.

    These are significant negative factors that could weigh on the stock price.

  • Competition and Stretched Valuation e.l.f. Beauty is gaining share, and valuation is stretched at nearly 198 times trailing earnings, with only 7% operating margin and $9.25 billion debt against $3.5 billion cash.

    This point highlights competitive pressures and financial weaknesses that could limit upside.

August 2026
▲2▼2

Estée Lauder's Turnaround Gains Traction, But Risks Loom

  • Strong Q4 results and raised outlook Estée Lauder reported fiscal Q4 sales up 6% to $3.63 billion and adjusted EPS of $0.39, and raised its fiscal 2027 operating-margin outlook. Shares jumped about 17% as investors cheered the progress.

    This is the main new positive development that drove the stock higher during the period.

  • Barclays upgrade on multi-year growth potential Barclays upgraded Estée Lauder, citing multi-year growth potential. Management also expects innovation to add 200–250 basis points to fiscal 2027 sales, reinforcing confidence in the turnaround.

    This new analyst action and guidance detail provided additional positive momentum for the stock.

  • Data breach and competitive pressures A data breach involving Oracle’s HR system creates regulatory and reputational exposure. Meanwhile, e.l.f. Beauty’s skincare brands are gaining share and challenging Estée Lauder’s prestige portfolio.

    These are new negative developments that could weigh on the stock and temper the positive momentum.

  • Stretched valuation and financial risks Operating margin is only 7%, net margin 1.21%, and debt totals $9.25 billion against $3.5 billion cash. The stock trades near 198 times trailing earnings, pricing in a major profit recovery that still must be delivered.

    This highlights the financial fragility and high expectations that pose a risk to the stock if the turnaround falters.

Latest
▲3

Estée Lauder's turnaround gains traction as margins recover and innovation accelerates

  • Q4 beat and raised margin outlook Estée Lauder reported fiscal Q4 net sales up 6% to $3.63 billion and adjusted EPS of 39 cents, then raised its fiscal 2027 adjusted operating-margin outlook to 12.7%-13.5% from 12.5%-13.0%. The stock jumped about 17% in August as investors saw the turnaround gaining traction.

    This is the core fundamental catalyst showing the company's profitability recovery is ahead of schedule.

  • Barclays upgrade on growth and earnings profile Barclays upgraded Estée Lauder to overweight from equal weight, citing its growth and earnings profile over the next several years. The stock rose 2.8% on the news, signaling that analysts see a multi-year profit recovery ahead, not just a one-quarter bounce.

    A major analyst upgrade validates the turnaround thesis and can attract new institutional buyers.

  • Innovation to lift fiscal 2027 sales Under its Beauty Reimagined strategy, Estée Lauder expects product innovation to add 200-250 basis points to fiscal 2027 sales, led by skin care. New launches from La Mer, Clinique, The Ordinary, and fragrance brands are planned. Innovation already accounted for 23% of fiscal 2026 sales.

    This shows a concrete, company-driven path to faster revenue growth beyond cost cuts.

  • Revenue grows but thin margins and debt weigh Revenue rose 6.3% but operating margin is only 7% and net margin just 1.21%, with $9.25 billion of debt against $3.5 billion in cash. The stock trades at nearly 198 times trailing earnings, so the market is pricing in a sevenfold profit recovery that must still be delivered.

    This is the key counterweight: the recovery is real but fragile, and the valuation leaves little room for error.

July 2026
▲3▼1

Estée Lauder's Turnaround Gains Traction as Profit Outlook Brightens

  • Goldman Sachs reinstates Buy, sees durable recovery Goldman Sachs reinstated coverage with a Buy rating and $100 target, saying investors underestimate the turnaround. It cited new leadership, the Beauty Reimagined strategy, and One ELC cost cuts that returned the company to growth after three down years. This boosts confidence and can pull the stock up.

    A major analyst endorsement directly supports the bull case and can attract buyers.

  • Restructuring charges rise to about $1.75 billion Estée Lauder now expects restructuring charges of roughly $1.75 billion, up from a prior $1.5–$1.7 billion range. The higher costs are tied to job cuts, digital upgrades, and office exits. This weighs on near-term profits and the stock, though the program should finish by fiscal 2027.

    Higher-than-expected restructuring costs are a real counterweight to the turnaround story.

  • Fiscal 2026 beat and strong 2027 guidance Estée Lauder beat fiscal 2026 targets, with organic sales up 3% and operating margin expanding 320 basis points to 11.2%. It guided fiscal 2027 EPS to $3.10–$3.35, above analyst estimates, and raised its operating margin outlook. This signals the turnaround is working and supports a higher stock price.

    The earnings beat and raised guidance are the core new fundamental drivers of the stock.

  • Luxury fragrance and China demand drive growth Strong demand for luxury fragrance and skincare, led by Le Labo and Tom Ford, drove 10% category sales growth. Mainland China delivered 9% organic growth with market share gains every quarter. This shows the company's key growth engines are firing, which can push the stock up.

    Demand strength in high-margin categories and China is a key reason the stock is moving higher.

▲3▼1

Estée Lauder's Turnaround Gains Traction as Profit Outlook Brightens

  • Goldman Sachs reinstates Buy, sees durable recovery Goldman Sachs reinstated coverage with a Buy rating and $100 target, saying investors underestimate the turnaround. It cited new leadership, the Beauty Reimagined strategy, and One ELC cost cuts that returned the company to growth after three down years. This boosts confidence and can pull the stock up.

    A major analyst endorsement directly supports the bull case and can attract buyers.

  • Restructuring charges rise to about $1.75 billion Estée Lauder now expects restructuring charges of roughly $1.75 billion, up from a prior $1.5–$1.7 billion range. The higher costs are tied to job cuts, digital upgrades, and office exits. This weighs on near-term profits and the stock, though the program should finish by fiscal 2027.

    Higher-than-expected restructuring costs are a real counterweight to the turnaround story.

  • Fiscal 2026 beat and strong 2027 guidance Estée Lauder beat fiscal 2026 targets, with organic sales up 3% and operating margin expanding 320 basis points to 11.2%. It guided fiscal 2027 EPS to $3.10–$3.35, above analyst estimates, and raised its operating margin outlook. This signals the turnaround is working and supports a higher stock price.

    The earnings beat and raised guidance are the core new fundamental drivers of the stock.

  • Luxury fragrance and China demand drive growth Strong demand for luxury fragrance and skincare, led by Le Labo and Tom Ford, drove 10% category sales growth. Mainland China delivered 9% organic growth with market share gains every quarter. This shows the company's key growth engines are firing, which can push the stock up.

    Demand strength in high-margin categories and China is a key reason the stock is moving higher.

▲2▼2

Estée Lauder's Q4 Beat and Turnaround Progress Drive Shares Higher

  • Q4 earnings beat and turnaround progress Estée Lauder reported fiscal Q4 revenue of $3.63 billion and adjusted EPS of $0.39, beating expectations. Sales rose 6% organically, and operating margin improved sharply. Management pointed to market share gains in mainland China and growth across most categories, signaling that the turnaround under CEO Stéphane de La Faverie is gaining traction. The stock jumped over 16% on the news.

    This is the main new event that directly answers why EL moved, with strong positive impact.

  • Raised margin guidance and reaffirmed sales outlook The company reaffirmed its fiscal 2027 sales outlook and raised guidance for adjusted operating margin, a key profitability measure. This suggests management is confident in its cost-cutting and restructuring efforts, including the One ELC initiative and a net reduction of about 10,000 jobs. The improved profitability outlook supports a higher stock price.

    Guidance is a forward-looking driver that investors weigh heavily, and it reinforces the positive earnings surprise.

  • Data breach raises regulatory and reputational risks Estée Lauder disclosed a data security incident involving a vulnerability in Oracle's HR system, where an unauthorized party accessed personal information of some customers. The company notified law enforcement and added safeguards. While the financial impact is unclear, such breaches can lead to fines, lawsuits, and reputational damage, potentially weighing on the stock.

    This is a new negative event that could affect EL's price and is not yet reflected in the earnings-driven rally.

  • Intensifying competition in skincare from e.l.f. Beauty e.l.f. Beauty's skincare brands—e.l.f. SKIN, Naturium, and rhode—are gaining scale and market share, with combined retail sales exceeding $1 billion. This directly challenges Estée Lauder's prestige skincare portfolio, especially in mass and masstige channels. Continued share gains by e.l.f. could pressure Estée Lauder's sales growth and pricing power.

    This is a new competitive development that poses a risk to EL's market position and future growth.

LOréal S.A. (OR.PA)

Q3 2026
▲3

L'Oréal gains on beauty shift, deals, and AI marketing

  • Strong H1 results and record margin H1 sales rose 6.5% like-for-like to €23.77bn with a record 21.3% operating margin, and Q2 beat expectations on haircare and mascara demand, showing resilient consumer appetite.

    This explains the fundamental strength that supported the stock during the period.

  • Strategic acquisitions and license wins L'Oréal secured the Gucci beauty license early, acquired Kering's beauty division for $4.7bn, Innovist and Onesto Labs, and is eyeing an Armani stake, expanding its brand portfolio.

    These deals are major strategic moves that could drive future growth and were new in the period.

  • Chinese consumers shift to premium beauty Chinese consumers are moving from luxury fashion to premium beauty, helping L'Oréal overtake LVMH as France's most valuable listed company, a significant market shift.

    This consumer trend directly boosted L'Oréal's relative valuation and market position.

  • AI marketing and bond raise, but risks remain AI now drives ~20% of marketing and a €2bn bond adds flexibility, but luxury missed forecasts, travel retail remains weak, and dealmaking plus the bond raise carry integration and leverage risks.

    This captures both the efficiency gains and the real counterweights that could pressure the stock.

September 2026
▲4

L'Oréal gains from China beauty shift, dealmaking and AI push

  • Chinese consumers shift to premium beauty Chinese shoppers are cutting back on luxury fashion but still buying premium skincare and cosmetics. L'Oréal's luxury beauty division in China grew 10% last quarter, and 37% of high-spending Chinese consumers plan to spend more on beauty next year. This supports demand for OR.PA.

    This is a core demand driver showing why L'Oréal is outperforming luxury peers in a key market.

  • L'Oréal becomes France's most valuable listed company L'Oréal overtook LVMH as France's most valuable listed company, helped by the 'lipstick effect' — when money is tight, people still treat themselves to affordable beauty items. L'Oréal shares are up about 5% this year while LVMH is down 35%, showing a clear investor preference for beauty over high fashion.

    This milestone reflects the market's recognition of L'Oréal's relative strength and the shift in consumer spending.

  • Dealmaking spree: Kering beauty, Onesto Labs, Armani stake L'Oréal bought Kering's beauty division for $4.7 billion, won approval to buy India's Onesto Labs, and is in talks for a minority stake in Giorgio Armani. These moves expand its luxury and consumer brands, deepen its fragrance and cosmetics reach, and add growth in India. They strengthen future earnings power.

    These deals are major capital actions that expand L'Oréal's portfolio and market reach, directly affecting its growth outlook.

  • AI-led marketing and €2bn bond for flexibility L'Oréal says nearly 20% of its marketing spend is now AI-led, improving efficiency and consumer targeting. It also priced a €2 billion bond to fund general corporate needs, giving it cheap, long-term money. Both support profit margins and future investments.

    These show operational efficiency gains and financial strength, which underpin the company's ability to grow and invest.

Latest
▲4

L'Oréal gains from China beauty shift, dealmaking and AI push

  • Chinese consumers shift to premium beauty Chinese shoppers are cutting back on luxury fashion but still buying premium skincare and cosmetics. L'Oréal's luxury beauty division in China grew 10% last quarter, and 37% of high-spending Chinese consumers plan to spend more on beauty next year. This supports demand for OR.PA.

    This is a core demand driver showing why L'Oréal is outperforming luxury peers in a key market.

  • L'Oréal becomes France's most valuable listed company L'Oréal overtook LVMH as France's most valuable listed company, helped by the 'lipstick effect' — when money is tight, people still treat themselves to affordable beauty items. L'Oréal shares are up about 5% this year while LVMH is down 35%, showing a clear investor preference for beauty over high fashion.

    This milestone reflects the market's recognition of L'Oréal's relative strength and the shift in consumer spending.

  • Dealmaking spree: Kering beauty, Onesto Labs, Armani stake L'Oréal bought Kering's beauty division for $4.7 billion, won approval to buy India's Onesto Labs, and is in talks for a minority stake in Giorgio Armani. These moves expand its luxury and consumer brands, deepen its fragrance and cosmetics reach, and add growth in India. They strengthen future earnings power.

    These deals are major capital actions that expand L'Oréal's portfolio and market reach, directly affecting its growth outlook.

  • AI-led marketing and €2bn bond for flexibility L'Oréal says nearly 20% of its marketing spend is now AI-led, improving efficiency and consumer targeting. It also priced a €2 billion bond to fund general corporate needs, giving it cheap, long-term money. Both support profit margins and future investments.

    These show operational efficiency gains and financial strength, which underpin the company's ability to grow and invest.

July 2026
▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

  • H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.

    This is the core earnings event that directly drives investor confidence and valuation.

  • Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.

    It confirms the growth trend and shows demand is holding up in key regions.

  • Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.

    It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.

  • Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.

    These deals show management actively deploying capital for future growth.

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

  • H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.

    This is the core earnings event that directly drives investor confidence and valuation.

  • Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.

    It confirms the growth trend and shows demand is holding up in key regions.

  • Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.

    It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.

  • Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.

    These deals show management actively deploying capital for future growth.